Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $111 Million
  • Q1 2025

Birchview Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $111 Million distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $41.8M, Corcept Therapeutics Inc with a value of $7.54M, Acadia Pharmaceuticals Inc with a value of $4.38M, Prothena Corp Public LTD CO with a value of $4.12M, and Biodesix Inc with a value of $3.61M.

Examining the 13F form we can see an decrease of $6.13M in the current position value, from $117M to 111M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $111 Million
Healthcare: $106 Million
Energy: $4.08 Million
ETFs: $1.17 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$314M
$4.12 Million 3.71% of portfolio
332,974
Q4 2024 Added 45.33%
$530M
$2.98 Million 2.68% of portfolio
161,000
Q2 2024 Added 13.87%
$1.42B
$2.93 Million 2.64% of portfolio
114,700
Q4 2023 Added 38.69%
$1.02B
$2.47 Million 2.23% of portfolio
138,000
Q3 2024 Added 21.31%
$977M
$1.94 Million 1.75% of portfolio
72,910
Q3 2024 Reduced 51.39%
$429M
$1.77 Million 1.59% of portfolio
88,404
Q4 2024 Added 34.48%
$535M
$1.4 Million 1.26% of portfolio
210,005
Q4 2023 Added 147.06%
$321M
$1.38 Million 1.25% of portfolio
164,947
Q4 2024 Added 136.06%
$711M
$940,000 0.85% of portfolio
88,697
Q3 2024 Reduced 77.45%
$389M
$773,000 0.7% of portfolio
67,002
Q4 2024 Reduced 18.29%
$1.93B
$704,000 0.63% of portfolio
21,000
Q3 2023 Reduced 52.38%
$953M
$666,000 0.6% of portfolio
30,006
Q3 2023 Reduced 0.02%
$1.91B
$579,000 0.52% of portfolio
16,000
Q4 2024 New
$1.32B
$552,000 0.5% of portfolio
31,000
Q4 2024 Added 55.0%
$521M
$492,000 0.44% of portfolio
20,000
Q1 2025 New
$1.3B
$436,000 0.39% of portfolio
50,000
Q4 2024 Added 66.67%
$688M
$325,000 0.29% of portfolio
40,300
Q4 2023 Reduced 0.74%
$1.98B
$312,000 0.28% of portfolio
8,000
Q4 2024 Reduced 50.0%
$1.59B
$300,000 0.27% of portfolio
40,000
Q2 2024 Added 100.0%
$552M
$276,000 0.25% of portfolio
26,000
Q4 2024 Added 111.38%
$910M
$271,000 0.24% of portfolio
24,584
Q4 2024 Added 3,587.66%
$1.76B
$228,000 0.21% of portfolio
28,000
Q4 2022 Reduced 26.32%
$420M
$210,000 0.19% of portfolio
30,000
Q3 2023 Reduced 50.0%
$370M
$151,000 0.14% of portfolio
20,000
Q2 2024 Reduced 20.36%
$354M
$152,000 0.14% of portfolio
15,000
Q4 2024 Added 114.29%
$1.07B
$147,000 0.13% of portfolio
10,013
Q1 2024 Reduced 50.0%
$310M
$104,000 0.09% of portfolio
27,985
Q4 2024 Reduced 10.64%
$311M
$45,000 0.04% of portfolio
24,000
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $111 Million
  • Prior Value $117 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 4 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email